NPI: 1235162645 · PETALUMA, CA 94954 · General Acute Care Hospital · NPI assigned 07/09/2006
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY FOR ENROLLMENT) |
| NPI Enumeration Date | 07/09/2006 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 39,265 | $2.00M |
| 2019 | 38,059 | $1.64M |
| 2020 | 30,378 | $1.31M |
| 2021 | 37,572 | $1.58M |
| 2022 | 45,937 | $1.84M |
| 2023 | 46,683 | $1.93M |
| 2024 | 45,144 | $1.90M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 22,177 | 19,296 | $1.77M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 26,184 | 22,992 | $1.51M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,529 | 2,431 | $827K |
| 93976 | 2,526 | 2,505 | $724K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 4,220 | 4,156 | $618K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5,437 | 4,975 | $449K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,127 | 2,056 | $409K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2,384 | 2,199 | $337K |
| J3490 | Unclassified drugs | 30,619 | 15,429 | $268K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 6,528 | 5,954 | $251K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4,873 | 4,274 | $245K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2,287 | 2,220 | $220K |
| 99201 | 1,355 | 849 | $199K | |
| 76830 | Ultrasound, transvaginal | 2,026 | 1,970 | $196K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,034 | 839 | $189K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 3,926 | 3,834 | $170K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,941 | 1,888 | $166K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,070 | 3,686 | $159K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,462 | 1,369 | $158K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 818 | 778 | $157K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 380 | 362 | $157K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,875 | 1,793 | $153K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,775 | 2,401 | $143K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2,260 | 698 | $114K |
| 80053 | Comprehensive metabolic panel | 12,889 | 11,463 | $113K |
| J2704 | Injection, propofol, 10 mg | 2,768 | 2,638 | $104K |
| 71046 | Radiologic examination, chest; 2 views | 4,044 | 3,908 | $104K |
| 97139 | 2,001 | 532 | $102K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 863 | 841 | $96K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 15,095 | 13,197 | $93K |
| 71045 | Radiologic examination, chest; single view | 5,415 | 5,058 | $92K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 259 | 255 | $91K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,483 | 2,265 | $89K |
| 73630 | 1,988 | 1,791 | $71K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,700 | 3,542 | $68K |
| 87631 | 1,296 | 1,150 | $65K | |
| 73610 | 1,361 | 1,274 | $55K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 5,292 | 4,670 | $54K |
| 73030 | 1,396 | 1,339 | $53K | |
| 72100 | 1,153 | 1,140 | $48K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 551 | 534 | $47K |
| 83880 | 1,788 | 1,708 | $46K | |
| 83605 | 5,170 | 4,456 | $45K | |
| 84484 | 5,210 | 4,351 | $44K | |
| 76641 | 375 | 367 | $43K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 648 | 596 | $42K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 368 | 355 | $42K |
| 73130 | 1,048 | 965 | $40K | |
| 0450 | Emergency room services | 269 | 245 | $38K |
| 76770 | 349 | 340 | $37K | |
| 73562 | 1,024 | 954 | $36K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,244 | 3,847 | $35K |
| Z7502 | 905 | 851 | $35K | |
| 83690 | 6,101 | 5,567 | $33K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 115 | 114 | $30K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 993 | 848 | $30K |
| 73564 | 658 | 602 | $27K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 2,225 | 1,679 | $27K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 486 | 471 | $25K |
| 73110 | 584 | 552 | $23K | |
| 76999 | 183 | 180 | $22K | |
| 87040 | 2,107 | 1,451 | $21K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,545 | 1,466 | $19K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 764 | 675 | $19K |
| 76536 | 236 | 227 | $19K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 748 | 704 | $19K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,809 | 1,511 | $18K |
| 77066 | Tomosynthesis, mammo | 105 | 103 | $18K |
| G0202 | Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 95 | 63 | $17K |
| 72125 | Computed tomography, cervical spine; without contrast material | 56 | 53 | $16K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,274 | 1,169 | $16K |
| 81001 | 5,095 | 4,798 | $16K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,231 | 1,924 | $15K |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,331 | 1,188 | $15K |
| 74018 | 576 | 549 | $15K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,094 | 1,933 | $14K |
| 85610 | 4,237 | 3,970 | $14K | |
| 85379 | 1,562 | 1,500 | $13K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,498 | 1,446 | $12K |
| 76642 | 158 | 150 | $12K | |
| 93971 | 93 | 90 | $12K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,775 | 1,708 | $12K |
| J2060 | Injection, lorazepam, 2 mg | 1,577 | 1,347 | $11K |
| 84145 | 591 | 553 | $11K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 24 | 24 | $9K |
| Z7610 | 736 | 346 | $9K | |
| 83735 | 1,736 | 1,557 | $9K | |
| 84443 | Thyroid stimulating hormone (TSH) | 641 | 611 | $9K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 253 | 243 | $8K |
| 81003 | 3,866 | 3,647 | $8K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 908 | 769 | $8K |
| 72050 | 119 | 119 | $7K | |
| 72110 | 108 | 104 | $7K | |
| 90715 | 153 | 150 | $6K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 941 | 883 | $6K |
| 99070 | 388 | 360 | $6K | |
| 81025 | 2,009 | 1,910 | $6K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 94 | 88 | $6K |
| 80306 | 378 | 369 | $6K | |
| 73221 | 14 | 12 | $6K | |
| 77065 | Tomosynthesis, mammo | 30 | 30 | $5K |
| 87400 | 538 | 526 | $5K | |
| 71271 | 36 | 36 | $5K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 13 | 13 | $5K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 68 | 68 | $5K |
| 72141 | 12 | 12 | $5K | |
| 73502 | 96 | 91 | $5K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 12 | 12 | $5K |
| 87077 | 627 | 610 | $4K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 25 | 25 | $4K |
| 80076 | 686 | 670 | $4K | |
| Z9725 | 82 | 81 | $4K | |
| 72040 | 87 | 87 | $3K | |
| 85730 | 665 | 632 | $3K | |
| 71250 | 14 | 14 | $3K | |
| 87081 | 547 | 509 | $3K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 411 | 368 | $3K |
| 97750 | 27 | 27 | $2K | |
| 73140 | 81 | 78 | $2K | |
| 87186 | 258 | 253 | $2K | |
| 82077 | 118 | 108 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 266 | 254 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | 192 | 180 | $2K |
| 80047 | 141 | 140 | $1K | |
| S0164 | Injection, pantoprazole sodium, 40 mg | 83 | 76 | $1K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 15 | 13 | $1K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 13 | 13 | $1K |
| 82962 | 357 | 277 | $997.27 | |
| 85027 | 211 | 193 | $966.54 | |
| 86901 | 422 | 395 | $907.24 | |
| 82550 | 194 | 184 | $870.04 | |
| 86900 | 404 | 377 | $839.48 | |
| 73560 | 28 | 26 | $819.00 | |
| 82805 | 40 | 39 | $748.56 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 29 | 29 | $719.52 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 29 | 29 | $716.88 |
| 72070 | 12 | 12 | $533.64 | |
| 82248 | 144 | 137 | $517.80 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 36 | 34 | $501.38 |
| 80143 | 27 | 26 | $448.69 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 58 | 52 | $432.80 |
| 86140 | 62 | 61 | $419.94 | |
| 87807 | 61 | 59 | $418.46 | |
| 86850 | 143 | 136 | $379.96 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 52 | 50 | $372.76 |
| 12001 | 12 | 12 | $340.80 | |
| 80179 | 27 | 26 | $336.17 | |
| 87420 | 138 | 115 | $322.92 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 28 | 26 | $264.14 |
| J7050 | Infusion, normal saline solution, 250 cc | 48 | 40 | $225.16 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 15 | 13 | $192.90 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 12 | 12 | $169.14 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 15 | 15 | $166.08 |
| 29125 | 14 | 14 | $165.62 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 30 | 26 | $135.45 |
| J1171 | Injection, hydromorphone, 0.1 mg | 12 | 12 | $118.75 |
| 85651 | 52 | 51 | $91.20 | |
| 82553 | 12 | 12 | $88.68 | |
| 87070 | 12 | 12 | $66.12 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 13 | 13 | $57.98 |
| 84100 | 14 | 12 | $46.84 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 83 | 74 | $1.78 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 14 | 12 | $0.84 |